Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: A comparison of their effects on hemodynamics and outcome
- 1 October 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 6 (5) , 542-553
- https://doi.org/10.1016/1053-0770(92)90096-p
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- PHOSPHODIESTERASE INHIBITORS DILATE HUMAN INTERNAL MAMMARY ARTERY IN VITROAnesthesiology, 1991
- A RANDOMIZED, BLINDED TRIAL OF AMRINONE, EPINEPHRINE, AND AMRINONE/EPINEPHRINE AFTER CARDIOPULMONARY BYPASS (CPB)Anesthesiology, 1991
- AMRINONE INHIBITS INTRACORONARY THROMBUS FORMATION AND PROTECTS AGAINST MYOCARDIAL ISCHEMIA IN DOGSAnesthesiology, 1988
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Intravenous amrinone in left ventricular failure complicated by acute myocardial infarctionThe American Journal of Cardiology, 1985
- Electrophysiologic effects of amrinoneThe American Journal of Cardiology, 1985
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.Circulation, 1980
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in man.Circulation, 1978